Rnf4 - ubch5a - ubiquitin heterotrimeric complex Deposition Author(s): Hay, R.T. , Jaffray, E. , Naismith, J.H. , Plechanovova, A. , Tatham, M.H.
Date: 2012-03-30 Method: X-RAY DIFFRACTION Resolution: 2.21 Å Organism(s): Homo Sapiens , Rattus Norvegicus Sequences Data: 4AP4_A , 4AP4_B , 4AP4_E , 4AP4_C , 4AP4_F
Pseudomonas aeruginosa rmla in complex with allosteric inhibitor Deposition Author(s): Alphey, M.S. , Gardiner, M. , Gray, D. , Naismith, J.H. , Pirrie, L. , Torrie, L.S. , Westwood, N.J.
Date: 2012-04-26 Method: X-RAY DIFFRACTION Resolution: 2.204 Å Organism(s): Pseudomonas Aeruginosa Sequences Data: 4ARW_A , 4ARW_B , 4ARW_C , 4ARW_D
Pseudomonas aeruginosa rmla in complex with allosteric inhibitor Deposition Author(s): Alphey, M.S. , Gardiner, M. , Gray, D. , Naismith, J.H. , Pirrie, L. , Torrie, L.S. , Westwood, N.J.
Date: 2012-05-01 Method: X-RAY DIFFRACTION Resolution: 2.25 Å Organism(s): Pseudomonas Aeruginosa Sequences Data: 4ASJ_A , 4ASJ_B , 4ASJ_C , 4ASJ_D
Pseudomonas aeruginosa rmla in complex with allosteric inhibitor Deposition Author(s): Alphey, M.S. , Brenk, R. , Gardiner, M. , Gray, D. , Naismith, J.H. , Pirrie, L. , Sarkar, A. , Torrie, L.S. , Westwood, N.J.
Date: 2012-05-03 Method: X-RAY DIFFRACTION Resolution: 2.3 Å Organism(s): Pseudomonas Aeruginosa Sequences Data: 4ASY_A , 4ASY_B , 4ASY_C , 4ASY_D
Crystal structure of pseudomonas aeruginosa inosine 5'-monophosphate dehydrogenase Deposition Author(s): Duthie, F. , Liu, H. , Mcmahon, S.A. , Moynie, L. , Naismith, J.H.
Date: 2012-05-25 Method: X-RAY DIFFRACTION Resolution: 2.23 Å Organism(s): Pseudomonas Aeruginosa Sequences Data: 4AVF_A , 4AVF_B , 4AVF_C , 4AVF_D
Crystal structure of the hypothetical protein pa4485 from pseudomonas aeruginosa Deposition Author(s): Alphey, M.S. , Duthie, F. , Liu, H. , Mcmahon, S.A. , Moynie, L. , Naismith, J.H.
Date: 2012-05-29 Method: X-RAY DIFFRACTION Resolution: 1.08 Å Organism(s): Pseudomonas Aeruginosa Pa01 Sequences Data: 4AVR_A , 4AVR_B
The aeropath project and pseudomonas aeruginosa high-throughput crystallographic studies for assessment of potential targets in early stage drug discovery. Deposition Author(s): Alphey, M.S. , Duthie, F. , Liu, H. , Mcmahon, S.A. , Moynie, L. , Naismith, J.H.
Date: 2012-05-30 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Pseudomonas Aeruginosa Pa01 Sequences Data: 4AVY_A , 4AVY_B
Medium resolution structure of the bifunctional kinase- methyltransferase wbdd Deposition Author(s): Hagelueken, G. , Huang, H. , Naismith, J.H.
Date: 2012-06-11 Method: X-RAY DIFFRACTION Resolution: 3 Å Organism(s): Escherichia Coli Sequences Data: 4AX8_A
High resolution (2.2 a) crystal structure of wbdd. Deposition Author(s): Hagelueken, G. , Huang, H. , Naismith, J.H.
Date: 2012-06-26 Method: X-RAY DIFFRACTION Resolution: 2.15 Å Organism(s): Escherichia Coli Sequences Data: 4AZS_A
Co-crystal structure of wbdd and kinase inhibitor ly294002. Deposition Author(s): Hagelueken, G. , Huang, H. , Naismith, J.H.
Date: 2012-06-26 Method: X-RAY DIFFRACTION Resolution: 2.34 Å Organism(s): Escherichia Coli Sequences Data: 4AZT_A